Tailoring Blood Pressure Targets After Endovascular Therapy in Acute Ischemic Stroke: Clinical Trial Insights
Highlight
This multicenter randomized clinical trial demonstrated that personalized blood pressure (BP) management guided by reperfusion quality after endovascular therapy for acute ischemic stroke significantly improved functional outcomes at 90 days compared to guideline-recommended BP targets. The intervention group experienced lower rates of hemorrhagic transformation without increased rates of symptomatic intracranial hemorrhage or mortality, endorsing a patient-specific approach to post-thrombectomy BP control.
Study Background
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
